BioCardia (BCDA)

2.35 -0.10 (4.08%)

Chart
Today 6M 1Y 5Y

Latest Headlines

BioCardia (BCDA) Starts Pivotal Trial Studying CardiAMP Cell Therapy Trial July 1, 2020 10:23 AM - StreetInsider BioCardia Announces Activation of Pivotal Trial Studying CardiAMP Cell Therapy Trial to Treat Chronic Myocardial Ischemia July 1, 2020 10:20 AM - Globe NewsWire BioCardia Announces CardiAMP Heart Failure Pivotal Trial Continues with First Patient Randomized in COVID-19 Era July 1, 2020 8:00 AM - Globe NewsWire BioCardia Announces CardiAMP Heart Failure Pivotal Trial Continues with First Patient Randomized in COVID-19 Era June 29, 2020 8:00 AM - Globe NewsWire BioCardia (BCDA) Prices 4.762M Share Common Offering at $2.10/Sh June 17, 2020 8:33 AM - StreetInsider BioCardia Announces Pricing of $10 Million Public Offering June 17, 2020 8:30 AM - Globe NewsWire BioCardia Reports First Quarter 2020 Financial Results and Business Highlights May 15, 2020 8:00 AM - Globe NewsWire BioCardia (BCDA) Announces Positive Preclinical Results Supporting Investigational NDA for Anti-Inflammatory Cell Therapy in Heart Failure May 5, 2020 7:41 AM - StreetInsider BioCardia Announces Positive Preclinical Results Supporting Investigational New Drug Application for Anti-Inflammatory Cell Therapy in Heart Failure May 5, 2020 7:00 AM - Globe NewsWire Biocardia Announces FDA-Recommended Modifications to Primary Endpoint for Cardiamp Cell Therapy Heart Failure Trial to Support Marketing Approval April 30, 2020 8:01 AM - Globe NewsWire BioCardia Awarded New U.S. Patent Covering Helix System for Local Biotherapeutic Delivery of Autologous and Allogenic Cells to the Heart April 28, 2020 3:08 PM - Globe NewsWire BioCardia Announces Litigation Financing in the Case Captioned Boston Scientific Corp., et al., v. BioCardia Inc. April 14, 2020 8:00 AM - Globe NewsWire BIOCARDIA REPORTS 2019 FINANCIAL RESULTS AND RECENT BUSINESS HIGHLIGHTS April 9, 2020 2:03 PM - Globe NewsWire Full Article List